Table: OncoTherapy Science -Q1 group results

OncoTherapy Science

07/08/2020 09:00

Aug 7 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            41 mln              55 mln                     
                 (-26.5 pct)        (+315.0 pct)                  
  Operating     loss 399 mln        loss 617 mln                  
  Recurring     loss 398 mln        loss 616 mln                  
  Net           loss 318 mln        loss 645 mln                  
  EPS           loss 1.81 yen       loss 4.18 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T